Articles
- Species-Specific Fc Receptor Proteins for Translational Research
- Fcε Receptor Proteins for Allergy and IgE Research
- Fcγ Receptor Proteins for Antibody Effector Function Research
- FcγRIIb (CD32B) Proteins for Inhibitory Immune Signaling Research
- Fcα Receptor and CD89 Proteins for IgA-Mediated Immunity
- FcRn Proteins for Antibody Half-Life and IgG Recycling Studies
- Fc Receptor-Like Proteins in B Cell Biology and Immune Regulation
- Fc Receptors in Monoclonal Antibody and Biosimilar Development
- Fc Receptors in ADCC, ADCP, and CDC-Related Antibody Function
- Fc Receptor Product Selection Guide
- Fc Receptor Products for Autoimmunity and Inflammation Research
- Fc Receptor Binding Assays for Antibody Drug Development
- Custom Fc Receptor Protein Expression and Engineering Services
- Biotinylated Fc Receptor Proteins for SPR, BLI, and Screening Assays
- CD16a / FcγRIIIa Proteins for ADCC Assay Development
- Why Endotoxin Levels Matter: Using Vaccine-Grade Proteins for Animal Immunization
- Technical Guide: Evaluating Neutralizing Antibody Titers Using NiV Pseudovirus Systems
- Optimized ELISA Protocol for Detecting NiV-Specific Antibodies Using Recombinant G/N Proteins
- Developing Rapid Diagnostics for Nipah Virus: Key Reagents for Lateral Flow Assays
- Accelerating Therapeutic Antibody Discovery: Phage Display & B-Cell Sorting with Biotinylated NiV Proteins
- Next-Generation Strategy for Nipah Virus Vaccine Development: From Antigen Design to Clinical Translation
- Interaction Mechanism of NiV Receptor Ephrin-B2/B3 and Applications in Drug Screening
- From Pre- to Post-Fusion: Conformational Changes and Epitope Mapping of Nipah Virus F Protein
- Broad-Spectrum Protection Against Henipaviruses: Focusing on Nipah Virus to Tackle Hendra and the Emerging Langya Virus